Adani Ports (ADANIPORTS) targets Evos in €2.56bn deal, but can debt-funded expansion deliver returns?
Read More Pharma Industry News How Purple Biotech’s CAPTN-3 platform achieved a tri-specific antibody manufacturing milestone with IM1240 Find out how Purple Biotech’s manufacturing milestone for IM1240 is validating the CAPTN-3 platform and transforming tri-specific antibody development. bySoujanya RaviOctober 29, 2025